SouthStar Capital closes financing for US medical products distributor
SouthStar Capital announced on June 12, 2026, that it has closed a specialized purchase order and accounts receivable financing facility for a United States-based medical products distributor. Becca Ripley, Director of Marketing for SouthStar Capital, confirmed the facility was designed to bridge a capital gap between an overseas manufacturer and the distributor’s nationwide customer base.
The funding directly supports a significant purchase order that the medical wholesaler had recently secured but lacked the immediate liquidity to fulfill.
The deal highlights the ongoing challenges small and mid-sized enterprises face when managing lengthy international lead times. By providing capital for supplier deposits and production costs, the firm allows the medical distributor to bypass the traditional credit constraints of a bank. This move ensures the domestic supply chain for medical products remains stable despite the financial strain of large-scale fulfillment.
As businesses continue to navigate volatile markets, supply chain resiliency increasingly prioritised over cost has become the new standard for survival. For this distributor, the financing acts as a safety net that covers the entire transaction lifecycle. It starts with the initial down payment to the overseas factory and extends through the final collection of receivables from American healthcare providers.
SouthStar Capital structures dual financing for medical distribution
The Mount Pleasant-based lender utilized a “piggyback” structure, combining Purchase Order (P/O) financing with Accounts Receivable (A/R) management. This dual-layered approach is often necessary when a borrower deals with international trade. Overseas manufacturers frequently demand upfront payments or letters of credit before production begins, which can stall growth for distributors with limited cash on hand.
The facility provides critical financial flexibility by funding the production phase and then transitioning into a factoring arrangement once the goods are shipped. This allows the company to continue expanding operations without waiting 30 to 90 days for customers to pay their invoices. The speed of this transaction was cited as a primary factor in the distributor’s ability to meet its contractual obligations.
Solving the international manufacturing liquidity gap
International product fulfillment presents a unique set of risks, including currency fluctuations and shipping delays. When an American distributor places an order with an overseas manufacturer, they often find their capital locked in “work-in-progress” status for months. SouthStar Capital’s intervention effectively thaws this frozen capital, turning a pending order into an active revenue stream.
Financial institutions are watching these types of private credit deals closely as traditional banking becomes more restrictive. While some leaders like UBS Asia President Iqbal Khan views AI as a big transformation for the banking sector’s efficiency, the human element of customized commercial finance remains essential for mid-market trade deals that don’t fit into standard algorithms.
Strategic implications for the domestic healthcare supply chain
The medical sector is particularly sensitive to fulfillment delays, as backorders can impact patient care across the United States. By securing this facility, the borrower ensures that their inventory levels remain robust enough to handle sudden spikes in demand. It also allows the company to maintain a strong relationship with its overseas manufacturer by guaranteeing on-time payments.
SouthStar Capital’s involvement goes beyond a simple loan; it serves as a vote of confidence in the distributor’s business model. The lender’s ability to fund domestic receivables while also financing foreign production is a capability that many regional banks lack. This specific deal demonstrates how alternative finance is filling the void left by tightening corporate credit markets.
Key features of the financing facility
- Full funding of production costs and supplier deposits for overseas manufacturing.
- Immediate liquidity upon the creation of accounts receivable.
- Scalable capital that grows in proportion to the distributor’s sales volume.
- Elimination of the “cash-flow gap” between inventory purchase and customer payment.
Commercial finance expansion in the South Carolina region
Operating from its headquarters in Mount Pleasant, South Carolina, SouthStar Capital has positioned itself as a nationwide player in the asset-based lending space. The company maintains a presence in major hubs like Atlanta and Charlotte to service a diverse portfolio of clients. This latest medical deal is part of a broader trend of SouthStar Capital diversifying into high-demand sectors like government contracting and healthcare.
The firm offers a suite of services including invoice factoring, equipment leasing, and payroll funding. These tools are becoming increasingly popular as businesses look for ways to leverage their own assets rather than taking on traditional debt. For the medical products distributor, this means the ability to take on larger contracts that would have previously been out of reach due to balance sheet limitations.
Looking ahead, the demand for purchase order financing is expected to rise as global trade routes face continued scrutiny and potential regulatory shifts. The Office of the U.S.
Trade Representative launches probe into Vietnam and other trade partners frequently, creating an environment where flexible financing is the only way to pivot quickly when tariffs or trade policies change. SouthStar Capital’s role in this ecosystem provides the necessary agility for American firms to compete on a global scale.